Pharmaceutical Industry
PoliticsWhite House estimates Trump’s Big Pharma dealmaking will save Americans $529 billion over the next 10 years
By Josh Boak and The Associated PressMay 5, 2026
C-SuiteWhy an exec at biopharma giant Gilead Sciences prefers energy management over time management
By Ruth UmohApril 13, 2026
SuccessOnly one U.S. university ranks in the world’s top 10 in STEM. Pfizer’s CEO is calling for change
By Preston ForeApril 3, 2026
By Jeff CollerMarch 26, 2026
CommentaryThe $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients
By Annette Bakker and Andrew W. LoMarch 19, 2026
By Jeffrey Sonnenfeld, Stephen Henriques, Ferron Chen, Asuka Koda and Vanessa McLennanFebruary 11, 2026
By Paul HudsonFebruary 10, 2026
By Jessica Nix, Madison Muller and BloombergFebruary 7, 2026
By Ruth UmohFebruary 2, 2026
SuccessPfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
By Preston ForeJanuary 31, 2026
C-Suite‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By Nick LichtenbergJanuary 30, 2026
HealthAs billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
Workplace CultureWalmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
By Sydney LakeJanuary 29, 2026
Most Popular
